Page last updated: 2024-08-23

transferrin and Adenoma, Oxyphilic

transferrin has been researched along with Adenoma, Oxyphilic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dehbi, HM; Hackshaw, A; Harmer, C; Mallick, U; Newbold, K; Wadsley, J1
Bongaerts, AH; Coppes, MH; Glaudemans, AW; Links, TP; Wolffenbuttel, BH1

Trials

1 trial(s) available for transferrin and Adenoma, Oxyphilic

ArticleYear
Recurrence after low-dose radioiodine ablation and recombinant human thyroid-stimulating hormone for differentiated thyroid cancer (HiLo): long-term results of an open-label, non-inferiority randomised controlled trial.
    The lancet. Diabetes & endocrinology, 2019, Volume: 7, Issue:1

    Topics: Adenocarcinoma, Follicular; Adenoma, Oxyphilic; Adolescent; Adult; Aged; Chemoradiotherapy, Adjuvant; Female; Humans; Iodine Radioisotopes; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Proportional Hazards Models; Radiotherapy Dosage; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyroidectomy; Thyrotropin Alfa; United Kingdom; Young Adult

2019

Other Studies

1 other study(ies) available for transferrin and Adenoma, Oxyphilic

ArticleYear
Unexpected symptoms after rhTSH administration due to occult thyroid carcinoma metastasis.
    The Netherlands journal of medicine, 2013, Volume: 71, Issue:5

    Topics: Adenocarcinoma, Follicular; Adenoma, Oxyphilic; Cervical Vertebrae; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neck Pain; Positron-Emission Tomography; Radiopharmaceuticals; Spinal Neoplasms; Thyroid Neoplasms; Thyrotropin Alfa

2013